In contrast, immunohistochemical staining for the apoptosis marker cleaved caspase-3 (Fig 7C and 7E) showed sAPRIL-BP treatment resulted in a significant and dose-dependent increase in apoptosis of tumor cells. Here, CASP3 is linked to neoplasm.